Ocular Imaging Study Using Advanced OCT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SD-OCT Angiography

NCT02510885

Neovascular Age-related Macular Degeneration Age-related Macular Degeneration Diabetic Retinopathy +2 more

TERMINATED NA

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

NCT01717937

TERMINATED

Imaging of the Angiofibrotic Switch in Neovascular AMD

NCT03838679

UNKNOWN

Retinal Investigation Using Optos OCT Device

NCT06846151

NOT_YET_RECRUITING NA

Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes

NCT02876744

Diabetic Retinopathy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Vascular Disorder Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retina abnormalities

Subjects with various retina vascular disorders

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Any patient with abnormal retinal findings as determined by investigators.

Exclusion Criteria

* Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
* Participants who are unable to maintain retinal fixation on a specified target.
* Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
* Patients with media opacity which preclude high quality imaging.

Minimum Eligible Age

18 Years

Maximum Eligible Age

115 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No